• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2022 Fiscal Year Final Research Report

Anti-inflammatory effect of gold nanoparticulate catalysts

Research Project

  • PDF
Project/Area Number 19K15410
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 28040:Nanobioscience-related
Research InstitutionTokyo University of Technology (2020-2022)
Tokyo Metropolitan University (2019)

Principal Investigator

Fujita Takashi  東京工科大学, 工学部, 助教 (30737565)

Project Period (FY) 2019-04-01 – 2023-03-31
Keywords金ナノ粒子 / 金属酸化物 / 抗炎症作用 / 担持金属触媒
Outline of Final Research Achievements

The synthesis of Au/MOx catalysts and the elucidation of their anti-inflammatory mechanism yielded the following noteworthy findings. Heat treatment in a reducing atmosphere was found to enhance the size dispersion of Au nanoparticles, contributing to improved catalytic performance. The anti-inflammatory effect of Au/MOx catalysts was observed through their internalization within cells, without compromising cell viability or phagocytic activity. Comparative analysis revealed that the order of anti-inflammatory effectiveness was Au/TiO2 > Au/ZrO2 > Au/CeO2, highlighting the significant role of MOx nanoparticles over the size of Au nanoparticles. Furthermore, the potential involvement of the antioxidant properties of Au/TiO2 and Au/ZrO2 in their anti-inflammatory effects was suggested. Collectively, these findings support the hypothesis that the anti-inflammatory action is synergistically mediated by the combined effects of Au NPs and MOx.

Free Research Field

ナノマテリアル

Academic Significance and Societal Importance of the Research Achievements

ナノ材料は表面積に基づく特性を持ち、薬剤輸送や触媒に利用されるが、生体への毒性が懸念される。特にMOxナノ粒子は炎症を引き起こす可能性がある。研究代表者はAu/TiO2やAu/ZrO2が抗炎症作用を示すことを発見している。本研究ではAu/MOx触媒の抗炎症機構の解明を試みた。Au/MOx触媒が示す抗酸化活性が抗炎症作用に関与している可能性が示された。しかし、それだけでは説明できない結果もあり、複合的な機構も考慮する必要があった。本研究の成果により、生体に優しい金属酸化物や抗炎症塗り薬の開発が期待され、炎症性疾患の予防・治療に貢献できる可能性がある。

URL: 

Published: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi